Digital PCR and Real-time PCR (qPCR) Market worth 5.31 Billion US$ till 2022 | Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, QIAGEN N.V, Takara Bio.

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Digital PCR and Real-time PCR (qPCR) Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Digital PCR and Real-time PCR (qPCR) Market spread across 215 Pages, profiling 15 companies and supported with tables and figures.

Get Free Sample Study Papers of “Digital PCR and Real-time PCR (qPCR) Market” at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1088567

Table of Contents
• Introduction
• Research Methodology
• Executive Summary
• Premium Insights
• Market Overview
• Industry Trends
• Global qPCR and dPCR Market, By Technology
• Global qPCR and dPCR Market, By Product and Service
• qPCR and dPCR Market, By Application
• qPCR and dPCR Market, By End User
• qPCR and dPCR Market, By Region
• Competitive Landscape
• Company Profiles
• Appendix

The Global dPCR and qPCR market is estimated to grow at a CAGR of 8.9% from 2017 to 2022, to reach US$ 5.31 Billion by 2022. The key factors driving the growth of this market include growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, and increasing use of biomarker profiling for disease diagnosis.

“The dPCR technology segment to grow at faster pace than qPCR technology segment during the forecast period.”
Based on the type of technology, the dPCR and qPCR market is classified into digital PCR (dPCR) and quantitative PCR (qPCR). In 2017, the qPCR technology segment is expected to account for the largest share of the market. However, the dPCR technology segment is expected to grow at the highest CAGR during the forecast period.

“Asia-Pacific to witness the highest growth during the forecast period (2017-2022)”
North America is expected to hold the largest share of the global dPCR and qPCR market in 2017, followed by Europe. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period. Growing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, growing public-private support to develop novel dPCR and qPCR technologies, strong growth witnessed by the Indian genomics industry, and advancing cancer research in Japan are the key factors responsible for the growth of this market in the Asia-Pacific region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–34% and Tier 3–21%
• By Designation – Director Level–14%, C-level–10%, Others–76%
• By Region – North America–40%, Europe–32%, Asia-Pacific–20%, RoW–8%

The Study Objectives of this report are:

• To forecast the size of market segments with respect to the four major regions, namely, North America (US and Canada), Europe (Germany, U.K., France, and Rest of Europe), Asia-Pacific (Japan, China. India, and Rest of APAC), and the Rest of the World

• To define, describe, and forecast the global digital PCR (dPCR) and quantitative PCR (qPCR) market on the basis of technology, product, application, and end users

• To provide detailed information regarding the major factors influencing the growth of the global dPCR and qPCR market (drivers, restraints, opportunities, and industry-specific challenges)

• To analyze the opportunities in the global dPCR and qPCR market for major stakeholders and to provide details of the competitive landscape for market leaders

• To track and analyze competitive developments such as new product developments; mergers & acquisitions; expansions; joint ventures, partnerships, collaborations, & agreements; and investments & funding in the dPCR and qPCR market

#Top Key Players in the “Digital PCR and Real-time PCR (qPCR) Market” include are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent Technologies Inc. (U.S.), bio Mérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.).

A Discount can be asked before order a copy of Digital PCR and Real-time PCR (qPCR) Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1088567

#Target Audience/Stakeholders for Digital PCR and Real-time PCR (qPCR) Market: qPCR and dPCR product manufacturing companies,Healthcare service providers (including hospitals and diagnostic centers),Research and development (R&D) companies,Pharmaceutical and biotechnology companies,Research laboratories and academic institutes,Clinical research organizations (CROs),Forensic laboratories,Market research and consulting firms,Government and independent regulatory authorities.

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

This release was published on openPR.